higher amounts of proteins, leading to higher rates of NP synthesis (Mohanpuria et al., 2008) . Several papers have been published describing the synthesis of silver NPs using mycosynthesis (Ahmad et al., 2003; Mishra et al., 2011; Soni et al., 2012; Gopinath et al., 2015) ; however, there is a continuing effort throughout the world to exploit fungal species in the nanotechnology field. A few reports have been published about nonpathogenic filamentous fungus Fusarium species and their capabilities in reducing aqueous silver ions extracellularly to generate silver NPs (Durán et al., 2005; Ahmad et al., 2010) . However, these previous studies did not cover the broad spectrum of silver NPs synthesized by the action of F. oxysporum against pathogenic bacteria and pathogenic yeasts.
In this study, the tested hypothesis is that a local isolate of filamentous fungus F. oxysporum tolerates heavy metals and actively synthesizes silver NPs extracellularly. Therefore, the main objectives of the present study were using F. oxysporum as a biocatalyst for the synthesis of NPs and investigation of their antimicrobial activity against some MDR isolates.
Materials and methods

Synthesis of AgNPs
A local isolate of F. oxysporum (F2A) was used for the synthesis of silver nanoparticles (AgNPs). Colonies of F. oxysporum were grown on potato dextrose agar (PDA) plates for 6 days at 28 °C and were used to inoculate 250 mL of MYPG medium (consisting of 3 g malt extract, 3 g yeast extract, 2 g peptone, and 10 g glucose per liter) in Erlenmeyer flasks. The flasks were incubated at 28 °C for 7 days with shaking at 150 rpm. Mycelial pads were harvested aseptically and washed 3 times with distilled water. The biomass of fungi was weighed and then used for the synthesis of nanoparticles applying an approach similar to that of Ahmad et al. (2003) and Durán et al. (2005) with some modifications. Briefly, three Erlenmeyer flasks were prepared; the first one contained 10 g of wet biomass and 100 mL of sterile distilled water and this flask was used as a negative control. The second flask included 10 g of mycelium pad and 100 mL of 1 mM silver nitrate (the metal solution was sterilized with a 0.22-µm Millipore filter). The third flask was also used as a negative control since it contained 100 mL of metal solution only. All flasks were incubated at 28 °C in the dark for 190 h with shaking at 150 rpm. Filtration and then centrifugation (at 5000 rpm for 20 min) were carried out, and then the supernatants were characterized.
Characterization of AgNPs
The synthesized NPs were characterized based on specific surface plasmon resonance peak, shape, size, and interaction between protein and NPs. To confirm the synthesis of AgNPs, 2 mL of sample was measured spectrophotometrically at a wavelength ranging from 300-600 using a Genesys 6 spectrophotometer (Thermo Electron, USA). Considering that the primary goal of this study was to produce a powerful antimicrobial nanomaterial, the agar well diffusion method was conducted to learn the antimicrobial properties of the NPs. Briefly, pathogenic bacterial isolates (Escherichia coli, Staphylococcus epidermidis, and Staphylococcus aureus) were grown in nutrient broth for 24 h at 37 °C. The number of cells per milliliter was adjusted to be 10 8 in a plate count procedure; 100 µL of inoculum (1 × 10 8 cells/ mL) was swabbed onto Mueller Hinton agar plates. Wells were made using gel puncture and then 0.1 mL of different dilutions of AgNPs (10%, 25%, 50%, 75%, and 100%) was loaded into certain wells. The plates were incubated at 37 °C overnight and then the zone of inhibition was measured (mm). This experiment was performed three times and then averages and standard deviations were calculated using Microsoft Excel. In accordance with the collected results of the agar well diffusion method, the NPs were subjected to microscopic identification via SEM (CamScan 3200LV, UK) and TEM (Philips CM10, the Netherlands) (procedure modified from Gurunathan et al., 2009) . To confirm the formation of AgNPs, atomic force microscopy (AFM; Phywe measure Nano, UK) was used. To identify the presence of possible biomolecules, Fourier transmission infrared spectroscopy (FT-IR; WQF-520 Biotech, UK) was applied.
Antimicrobial activity of AgNPs
All pathogenic microbes obtained from Sulaimani Teaching Hospitals in Kurdistan Region, Iraq, were MDR. The activity of AgNPs was tested against pathogenic microbes using growth inhibition by using microtiter plate. Growth inhibition assays were performed on Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis. Fresh overnight cultures of pathogenic bacterial isolates were adjusted to be 10 8 cells/mL as mentioned previously. A bacterial culture of 120 µL was placed in 96-well microtiter plates and then 80 µL of an appropriate dilution of AgNPs (25%, 50%, 75%, and 100%) was added. Nutrient broth (200 µL) was used as a negative control and 120 µL of bacterial culture mixed with 80 µL of fungal extract was also applied as a negative control. The microtiter plates were incubated at 37 °C for 18 h (modified procedure of Salem et al., 2015) . The optical density (OD) at 600 nm was measured using a microplate spectrophotometer (Biotech μQuant, USA). From each well, 5 µL was taken and spotted onto nutrient agar plates, and then all plates were incubated at 37 °C for 18 h. Growth percentage was calculated based on the average and standard deviation of triplicate results. For pathogenic fungi (Candida albicans and Candida krusei), the same method as mentioned above was used, except that the medium was replaced with potato dextrose broth and PDA. The number of cells per milliliter was adjusted to be 10 6 using a hemocytometer.
Results
Synthesis and characterization of AgNPs
F2A was able to convert AgNO 3 into AgNPs after 190 h of incubation as noticed visually by color change from white to light brown, whereas the control vessels developed no change in their original color (Figure 1 ; inset). The wavelength scan of UV-Vis spectra revealed a broad peak between 408 and 411 nm, indicating the surface plasmon resonance nature of the AgNPs that is present in the brown supernatant ( Figure 1) . Interestingly, the colored solution of AgNPs displayed a powerful inhibition against the clinical isolates ( Figure  2 ). Bacterial growth was inhibited even at the lowest concentration. From the average values of inhibition zones ( Figure 2 , insets), the highest antimicrobial activity was observed against S. epidermidis, which was 14 mm in diameter, whereas the cultures of S. aureus and E. coli also showed clear zones of inhibition, which were about 13 and 12.25 mm in diameter, respectively. Moderate antibacterial activity was noticed at a lower concentration of AgNPs (25%), while it was weak in 10% AgNPs against the tested bacteria.
SEM was used to determine the presence and size of AgNPs. After drying, the thin layer of AgNPs was analyzed. The scanning electron micrograph showed the presence of high-density AgNPs with mainly spherical shape ( Figure 3A , white arrows). The data obtained from TEM micrographs show that the synthesized AgNPs have a spherical shape and the size ranged from 21.3 to 37.3 nm, uniformly distributed without significant agglomeration ( Figure 3B , black arrows). A two-dimensional horizontal cross-section of the AgNPs by AFM indicated that the surface topography of the synthesized silver nanoparticles was almost spherical in shape ( Figure 3C ). Histogram analysis revealed that the mean particle size was approximately 21.5 nm.
The absorption peaks of AgNPs (Figure 4 ) are located at 538, 679, 768, 847, 1070, 1340, 1432, 1516, 1630, 2943, and 3411 cm -1 in the region of 500-400 cm -1
. The band at 1630 cm -1 is assigned to the stretching vibration of -C=O (carbonyl), identified as the amide I band, whereas the bands at 3411 cm -1 and 1516 cm -1 represent stretching and bending vibrations of -NH, respectively.
Antimicrobial activity of AgNPs
The effectiveness of AgNPs on MDR clinical isolates was determined by comparing growth rates under control and test conditions (Figures 5-7 ). AgNPs showed antimicrobial properties against all tested microbes; however, their exact effect on microbes was not clearly understood and was not investigated in this study. As seen in Figure 5 , at a concentration of 25% (v/v) AgNPs, Enterobacter cloacae, E. coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae were inhibited significantly, whereas 25% AgNP concentration showed no significant effect on Proteus mirabilis. In addition, similar behavior was exhibited at 25% and 50% concentrations against both Pseudomonas aeruginosa and Klebsiella pneumoniae.
All gram-negative bacteria used here were inhibited significantly; the highest antimicrobial activity was observed against E. coli and Proteus mirabilis, whose growths were restrained at the AgNP concentration of 50%. On the other hand, at a relatively high concentration (75%) of AgNPs, the growth of the other isolates was suppressed. In Figure 6 , two gram-positive bacteria are shown. The concentration of AgNPs also halted the growth of these bacteria. It seems that S. epidermidis tolerates up to about 50% of AgNPs in comparison with S. aureus.
In Figure 7 , the fungicidal effect is observed at a concentration of 50% (v/v) against Candida albicans while Candida krusei showed a high degree of resistance.
Discussion
Many questions remain unanswered about the resistance mechanisms of fungal strains towards many inhibitors such as heavy metals. Although fungi possess many properties that influence metal toxicity, the mechanisms involved in metal tolerance are highly dependent on the metabolic and nutritional status of the organism (Salem et al., 2015) . In this study, silver nitrate has halted the growth of 7 species of Fusarium except the F2A isolate (data not shown); F2A survived the effects of 1 mM silver. F2A might develop a new survival strategy as an adaptive response to unfavorable environmental conditions. Consequently, F2A was selected as a biocatalyst for the synthesis of AgNPs. F2A was able to reduce silver ions to silver NPs since it is well known that AgNPs in aqueous solutions show a yellowish brown color (Ahmad et al., 2003) . This bioreduction occurred through catalysis by the reducing agent secreted from the F2A biomass into the solution. Fusarium species have been used previously for NP production (Ahmad et al., 2003; Durán et al., 2005;  Gadd, 2007); however, previous studies did not cover the broad spectrum of silver NPs synthesized by the action of F. oxysporum against pathogenic bacteria and pathogenic fungi. The slow silver reduction (~190 h) could be the result of unfavorable growth conditions, due to the presence of relatively high concentrations of silver nitrate. The formation of silver NPs might occur by the action of reductase enzyme(s) excreted during fungal growth phases (Durán et al., 2005) . However, the restricted growth rate of the fungus in such batch cultures may perhaps lead to the delayed excretion of the enzyme(s), which leads to the slow reduction of silver nitrate. Notably, this long period of time gives stable AgNPs, as mentioned below. Thereafter, the colored solution was tested and analyzed spectrophotometrically using UV-Vis in the scan range of 300-600 nm (Figure 1 ). Interestingly, AgNPs absorbed light at different wavelengths and were excited due to charge density at the interface between conductor and insulator to give a respective peak on UV-Vis spectrophotometry (Gurunathan et al., 2015) , which is in agreement with several other studies (Rodríguez-León et al., 2013; Kumar et al., 2016) . These results suggest that the biopolymer protein plays a key role in providing stability to AgNPs. The biopolymer forms a ligand-shell surrounding AgNPs at the core, forming a silver polymer core-shell structure. The polymeric shell decreases the surface potential that is responsible for accumulation of the silver nanoparticles to larger aggregates (Busi et al., 2014) . Frequently, microbes are considered dead when they cannot be cultured. However, variation in the size of inhibition zones depends upon a number of factors such as the type of pathogens, synthesis method, and concentrations of AgNPs. It was observed in this study that increasing the concentration (v/v) of AgNPs in wells led to consistently increasing zones of inhibition ( Figure  2 ). At 40 mg/mL, AgNPs showed a good inhibitory zone against various pathogenic bacteria (Gopinath et al., 2015; Sanyasi et al., 2016) . Gopinath et al. (2015) showed that the shapes of AgNPs synthesized by F. oxysporum were spherical to oval in shape with little aggregation. The SEM micrographs of silver NPs show aggregated particles due to the capping agent(s), mainly metabolites of the action of microbes ( Figure 3A ). Therefore, the particle sizes measured by SEM can be larger than the sizes measured by TEM or XRD (Durán et al., 2005) . TEM images have provided evidence of extracellular synthesis of AgNPs (Kowalczyk et al., 2011) . TEM is widely used to analyze the structure and size of NPs and in this study it was used to determine the size and shape of silver NPs ( Figure 3B) . Basavaraja et al. (2008) synthesized AgNPs ranging from 8 to 60 nm with polydispersity and mostly spherical in shape. Ahmad et al. (2003) obtained AgNPs with a size of 5-50 nm with a spherical shape. Together, SEM and TEM analysis provide further insight into the morphology and particle size distribution profile of the AgNPs synthesized by F. oxysporum. Besides SEM and TEM techniques, AFM was used to obtain information about the effect of solution chemistry on the AgNPs' dissolution kinetics. In this case, aggregation cannot occur because the particles are immobilized. AFM is an obvious choice for characterizing dissolutive changes in the size and shape of AgNPs since it can resolve sample topography with subnanometer precision. The three-dimensional images showed the average roughness and inhomogeneity of the cluster formation of AgNPs ( Figure 3C ). On the other hand, Majeed et al. (2016) showed that AgNPs were spherical and 30-50 nm in size. FT-IR measurement was performed to identify the possible biomolecules responsible for the capping and efficient stabilization of the metal nanoparticles and to understand the protein/metal NP interaction. The FT-IR spectroscopic analysis clearly reveals that proteins are responsible for the reduction and stabilization of AgNPs ( Figure 4 ). Many studies have proved that bands at 1516 cm -1 in addition to C=O (carbonyl) stretching and -N-Hstretching vibrations correspond to the amide linkages of proteins (Hamedi et al., 2014; Luna et al., 2016) . Hamedi et al. (2014) showed that the appearance of peaks in the amide I and amide II regions describes proteins and/or enzymes that have been found to be responsible for the reduction of metal ions when using microorganisms as biocatalysts. It seems that the F2A metabolites play dual functions in the formation and stabilization of AgNPs.
In the 1940s, western industries began to focus on the production of fungal-specific secondary metabolites by the cultivation of the fungi on relatively raw materials using submerged and solid state cultures. Since then, tremendous medically significant metabolites (such as antibiotics) are being produced, purified, and sold for medicinal purposes. Antibacterial activities of AgNPs in this report have been investigated against MDR grampositive and gram-negative bacteria (Figures 5 and 6 ). This resistance might be attributed to the presence of a self-produced extracellular matrix in both isolates and its roles in the defense mechanisms (Jagnow et al., 2003; Periasamy et al., 2015) . Moreover, cells may be inactive or damaged and therefore unable to reproduce temporarily. With time and appropriate conditions, the cells may recover and begin to reproduce. The presence of multiple mechanisms to avoid inhibitors in some clinical strains allow them to survive and resist the most commonly used drugs. This tolerance could be due to specific antibiotic resistance genes and the formation of biofilms (Otto, 2009) . Although the inhibition of bacterial growth indicates that AgNPs possess a bactericidal property, the mechanisms that contribute to cell death remain vague. One hypothesis is that AgNPs are involved in the disruption of the membrane with a generation of reactive oxygen species and ultimately lead to the death of pathogens (Prabhu and Poulose, 2012) . Another possibility is that AgNPs have the ability to adhere to the bacterial cell wall and produce cracks and pits, through which the internal cell contents are released (Feng et al., 2000) . The efficacy of AgNPs against pathogenic yeasts was evaluated by identifying growth percentage in a 96-well microtiter plate. More importantly, the AgNPs produced by F. oxysporum exhibited potent antifungal activity against two species of Candida ( Figure  7 ). Although Candida krusei is an uncommon clinical isolate, it does tolerate a broad array of antifungals (Pfaller et al., 2008) . Therefore, finding a robust agent is necessary for many opportunistic pathogens like Candida krusei. A previous study showed that AgNPs biosynthesized by the fungus Arthroderma fulvum showed considerable antifungal activity against Candida species (Xue et al., 2016) . Lara et al. (2015) found that AgNPs caused severe morphological changes in fungal cells manifested by disruption of the cell membrane structure.
In conclusion, the AgNPs synthesized by F. oxysporum were characterized as spherical to oval in shape with average size ranging between 21.5 and 37.3 nm. The AgNPs remained stable with a slight change in color. However, the peak of surface plasmon resonance remained unchanged with the same region after storage for 4 months under 4 °C cooling conditions (data not shown). Obviously, pathogenic bacteria continue to develop resistance to a long list of antibiotics, leading to untreatable infections. AgNP-producing F2A shows promise as an effective biocatalyst and its Ag nanoparticles have powerful lethality against MDR microbes. AgNPs showed inhibitory effects against all MDR bacteria used in this study. AgNPs also displayed antifungal activity against pathogenic yeasts. For future work, the toxicity of AgNPs needs to be studied to establish that the benefits of using nanoparticles outweigh the potential risks.
